Nuformix (LSE:NFX) Operating Cash Flow per Share : £0.00 (TTM As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Operating Cash Flow per Share?

Nuformix's operating cash flow per share for the six months ended in Sep. 2022 was £0.00. Nuformix's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2022 was £0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Nuformix's Operating Cash Flow per Share or its related term are showing as below:

LSE:NFX's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Nuformix Operating Cash Flow per Share Historical Data

The historical data trend for Nuformix's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Operating Cash Flow per Share Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Operating Cash Flow per Share

Get a 7-Day Free Trial

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Operating Cash Flow per Share	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Nuformix's Operating Cash Flow per Share

For the Biotechnology subindustry, Nuformix's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuformix's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuformix's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nuformix's Price-to-Operating-Cash-Flow falls into.

Nuformix Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Nuformix's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2022 is calculated as

Operating Cash Flow per Share (A: Mar. 2022 )	=	Cash Flow from Operations (A: Mar. 2022 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2022 )
	=	-1.346	/	598.448
	=	-0.00

Nuformix's Operating Cash Flow per Share for the quarter that ended in Mar. 2022 is calculated as

Operating Cash Flow per Share (Q: Sep. 2022 )	=	Cash Flow from Operations (Q: Sep. 2022 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2022 )
	=	-0.338	/	707.261
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00

Nuformix Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Nuformix's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.